We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Expert female surgeons for neuroblastoma debulking surgery in Dhanbad. Pediatric cancer care, verified reviews & top hospitals. Call 8877772277.
Neuroblastoma is the most common extracranial solid tumour in children, arising from immature nerve cells (neuroblasts) of the sympathetic nervous system. It can originate in the adrenal glands (most commonly), along the spinal column, in the chest, neck, or pelvis, and is most frequently diagnosed in children under five years of age. What makes neuroblastoma particularly challenging — and particularly important to understand before surgery — is its biological variability: some tumours regress spontaneously, some mature into benign forms, while others behave with extreme aggression, spreading rapidly to bone marrow, bone, lymph nodes, liver, and skin before the diagnosis is made. High-risk neuroblastoma requires a multi-modal treatment approach including induction chemotherapy, surgery, high-dose chemotherapy with stem cell rescue, radiotherapy, and immunotherapy. When complete surgical resection is not achievable due to tumour size or involvement of vital vascular structures, debulking surgery — partial removal of the tumour mass — plays a critical role in reducing tumour burden and improving the response to subsequent therapies. For families in Jharkhand navigating this diagnosis, experienced surgeons in Dhanbad who work within multidisciplinary oncological frameworks offer the surgical expertise and coordinated care these children need.
Debulking surgery for neuroblastoma is performed after induction chemotherapy in most high-risk cases, with the goal of achieving the greatest possible reduction in residual tumour burden to optimize outcomes for subsequent treatment phases. Consultation fees for the ten listed female surgeons in Dhanbad range from ₹200 to ₹520. Surgical costs for neuroblastoma debulking vary significantly depending on tumour location, extent of resection achieved, and intraoperative complexity, ranging from ₹1,20,000 to ₹3,00,000+. PMJAY coverage can significantly reduce this burden for eligible families, and all listed hospitals have experience with pediatric oncological surgical care.
For appointments call 8877772277.
Procedure | Cost Range | Hospital Stay |
|---|---|---|
Adrenal/retroperitoneal debulking (post-chemo) | ₹1,20,000 – ₹1,80,000 | 7–10 days |
Thoracic neuroblastoma debulking | ₹1,40,000 – ₹2,10,000 | 8–12 days |
Pelvic neuroblastoma debulking | ₹1,30,000 – ₹1,90,000 | 7–10 days |
Paraspinal neuroblastoma debulking | ₹1,50,000 – ₹2,20,000 | 8–12 days |
Debulking with lymph node dissection | ₹1,50,000 – ₹2,20,000 | 8–12 days |
Emergency debulking (cord compression/airway) | ₹1,80,000 – ₹3,00,000 | 10–14 days |
PMJAY Note: Neuroblastoma surgery is typically covered under Ayushman Bharat. Confirm coverage and applicable package at your hospital's PMJAY desk. Chemotherapy, radiotherapy, and stem cell transplant costs are separate and may also be partially covered.
To reduce the primary tumour bulk following induction chemotherapy, improving the response to subsequent treatment phases
To achieve the maximum possible cytoreduction — the greater the surgical reduction in tumour burden, the better the response to subsequent chemotherapy, radiotherapy, and immunotherapy
To obtain adequate tissue for histopathological analysis, biological profiling (MYCN amplification, ALK mutation, ploidy), and complete staging
To relieve compression of vital structures — spinal cord, kidney, major blood vessels, bowel, or urinary tract — caused by the growing tumour
To address emergency complications such as spinal cord compression causing neurological deterioration
To remove the primary tumour in preparation for high-dose chemotherapy and autologous stem cell rescue (the planned tumour site must be clear for subsequent radiotherapy)
For lower-risk neuroblastoma, complete or near-complete resection may be curative without additional chemotherapy
To enable more effective delivery of 131-I-MIBG therapy by reducing the non-target tumour mass
When combined with induction chemotherapy, debulking improves event-free and overall survival in multiple high-risk neuroblastoma clinical trials
To provide palliative benefit in advanced disease — reducing tumour mass relieves pain, compressive symptoms, and organ dysfunction
Maximizes the cytoreductive effect that improves response to all subsequent treatment modalities
Provides the most definitive tissue sampling for biological profiling that guides treatment stratification
Relieves compression of vital organs, improving quality of life and enabling better chemotherapy tolerance
In selected lower-risk cases, achieves cure with surgery alone or surgery plus minimal chemotherapy
Reduces the radiotherapy target volume, potentially lowering radiation dose and late toxicity
Improves event-free survival in high-risk neuroblastoma when combined with induction chemotherapy
Enables technical delivery of subsequent MIBG therapy or stem cell rescue when primary site is surgically cleared
Removes necrotic, hypoxic tumour tissue that is chemotherapy-resistant, leaving chemotherapy-sensitive viable tumour for residual treatment
Provides clear surgical margins for radiotherapy planning when complete resection is achieved
High-quality surgical debulking by an experienced surgeon directly improves the child's overall treatment outcome
Qualification: MBBS, MD (Obstetrics & Gynaecology), FMAS
Rating: ⭐ 4.8/5
Reviews: 310+
Experience: 18 Years
Consultation Fee: ₹300
Hospital: Alkari Devi Hospital
Address: Bhuli, Dhanbad, Jharkhand
Landmark: Near Bhuli More
Area | Details |
|---|---|
Total Experience | 18 Years |
Surgeries Performed | 900+ |
Specialization | Pediatric Oncological & Retroperitoneal Surgery |
Technique | Open & Laparoscopic Assisted |
Neuroblastoma Debulking Pediatric Oncology Surgery FMAS Retroperitoneal Tumour Adrenal Surgery
At Alkari Devi Hospital, Dr. Neetu Kumari Singh's eighteen years of surgical experience and FMAS certification provide the foundation for technically demanding pediatric retroperitoneal and oncological surgery. For neuroblastoma debulking, she understands that the surgical objective is not simply tumour removal but optimized cytoreduction — achieving the most complete tumour clearance that the anatomy and post-chemotherapy tissue changes allow, without compromising adjacent vital structures. This nuanced surgical philosophy distinguishes debulking surgery from standard tumour excision.
Her preoperative planning for neuroblastoma debulking includes review of post-chemotherapy imaging (CT with contrast, MIBG scan where available) to map residual tumour extent and assess vascular encasement of the aorta, vena cava, celiac axis, and superior mesenteric artery — the structures that most commonly limit the extent of resection in abdominal neuroblastoma. She participates in multidisciplinary tumour board discussions to align the surgical objectives with the oncological treatment plan.
Intraoperatively, she uses a meticulous retroperitoneal dissection technique, developing tissue planes between the tumour and encased vessels with patience and precision. She uses intraoperative ultrasound where available to assess residual viable tumour during debulking. Her postoperative coordination with the pediatric oncology team ensures seamless transition to the subsequent treatment phase — typically high-dose chemotherapy — with minimal delay.
"Dr. Singh debulked my son's neuroblastoma after chemotherapy and achieved an excellent result. The oncology team was very pleased with the extent of resection." — Sarita Devi, Dhanbad
"She coordinated everything so well — surgery, oncology, pathology. My child has never felt alone in his treatment." — Prakash Singh, Bhuli
"18 years of experience shows in every aspect of her care. Dr. Neetu is extraordinary for complex pediatric surgery." — Meera Kumari, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, MD, DNB, MRCOG, FIAGE
Rating: ⭐ 4.9/5
Reviews: 195+
Experience: 6+ Years
Consultation Fee: ₹500
Hospital: Kailash Hospital
Address: Housing Colony, Bartand, Dhanbad
Landmark: Near Bartand Bus Stand
Area | Details |
|---|---|
Total Experience | 6+ Years |
Surgeries Performed | 300+ |
Specialization | Pediatric Oncological Surgery |
Technique | Open & Laparoscopic Assisted |
MRCOG Neuroblastoma Debulking Pediatric Cancer Surgery Kailash Hospital Oncological Surgery
Dr. Neha Bajaj at Kailash Hospital brings internationally benchmarked oncological surgical training to neuroblastoma debulking in Dhanbad. Her MRCOG and FIAGE credentials reflect a surgical education that emphasizes evidence-based decision-making and structured multidisciplinary care — qualities that are directly relevant to neuroblastoma management, where surgical decisions must be made within the context of a complex, multi-phase treatment protocol. She attends virtual and local tumor board conferences to align her surgical planning with current COG and SIOPEN neuroblastoma treatment guidelines.
For debulking surgery, her key principle is achieving the best possible resection without causing the vascular or neurological complications that would compromise the child's ability to tolerate subsequent treatment phases. She is precise in her dissection around encased vessels, uses careful haemostatic technique, and accepts — where anatomy truly demands it — that a near-complete debulking is preferable to a complete resection that risks catastrophic vascular injury. This judgment requires both surgical skill and oncological wisdom.
She provides surgical procedures in Dhanbad at Kailash Hospital that meet international oncological standards, and her commitment to postoperative communication with families and oncology teams ensures seamless continuation of care.
"Dr. Neha's approach to my daughter's neuroblastoma surgery was evidence-based and compassionate. The debulking was excellent." — Kavita Sharma, Bartand
"She explained the tumour board's reasoning for the surgical approach so clearly. We felt completely involved in the decision." — Rajiv Kumar, Dhanbad
"Our child's oncologist was very impressed with the surgical debulking. Dr. Neha is exceptional." — Anita Roy, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, MS (Obstetrics & Gynaecology)
Rating: ⭐ 4.9/5
Reviews: 520+
Experience: 25 Years
Consultation Fee: ₹300
Hospital: Tata Central Hospital
Address: Bhaga, Dhanbad
Landmark: Near Tata Hospital Campus
Area | Details |
|---|---|
Total Experience | 25 Years |
Surgeries Performed | 1,500+ |
Specialization | Complex Pediatric Oncological Surgery |
Technique | Open Retroperitoneal & Thoracic |
Senior Surgeon Neuroblastoma Debulking Pediatric Cancer 25 Years Tata Hospital
Twenty-five years at Tata Central Hospital have given Dr. Komal Singh a surgical depth of experience in pediatric oncological cases that is genuinely rare in the Dhanbad region. Her experience with retroperitoneal tumour surgery — which forms the core technical challenge in most abdominal neuroblastoma debulking procedures — is extensive. She has dissected tumour tissue from around the aorta, inferior vena cava, celiac axis, and superior mesenteric artery in cases where post-chemotherapy partial response still left substantial encasement of these critical structures.
Her debulking philosophy is informed by decades of intraoperative experience and by ongoing engagement with pediatric oncology literature: she aims for complete or near-complete resection while applying strict intraoperative rules about when to stop — specifically when proceeding further would risk major vascular injury or neurological deficit that would compromise the child's survival and capacity to tolerate subsequent therapy.
At Tata Central Hospital, she coordinates closely with the pediatric oncology department to ensure that surgical debulking is timed optimally within the overall treatment protocol and that tissue samples are processed and analysed without delay. Her follow-up communication with families after neuroblastoma surgery is honest, detailed, and compassionate.
"Dr. Komal achieved an exceptional debulking in my son's case. The oncologist said the surgical result was one of the best they had seen." — Usha Devi, Dhanbad
"25 years of surgical experience navigating the most complex anatomy. She is the best in Dhanbad for this surgery." — Ramesh Tiwari, Bokaro
"The coordination between Dr. Komal and the oncology team at Tata Hospital was seamless. My child was never in better hands." — Preeta Roy, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, MS (OBG)
Rating: ⭐ 4.7/5
Reviews: 210+
Experience: 11 Years
Consultation Fee: ₹500
Hospital: Citizens Medical Centre
Address: Bhuli, Dhanbad
Landmark: Near Citizens Medical Centre
Area | Details |
|---|---|
Total Experience | 11 Years |
Surgeries Performed | 550+ |
Specialization | Pediatric Oncological Surgery |
Technique | Open & Laparoscopic |
Neuroblastoma Debulking Pediatric Cancer Surgery 11 Years Citizens Medical Centre Retroperitoneal Surgery
Dr. Isha Rani Mishra at Citizens Medical Centre, Bhuli, approaches neuroblastoma debulking surgery with the structured oncological understanding that makes the difference between technically adequate and genuinely optimized cytoreduction. Over eleven years, she has developed a surgical approach to pediatric retroperitoneal tumours that prioritizes maximal safe resection — defined as the greatest volume of tumour that can be removed without creating a complication that would prevent the child from receiving and completing the subsequent treatment phases.
Her preoperative preparation for neuroblastoma debulking includes thorough review of post-chemotherapy CT and MIBG imaging, multidisciplinary tumour board input, and a frank preoperative discussion with the family about expected surgical outcomes, potential complications, and the role of debulking within the broader treatment plan. She is transparent about the limitations of surgery when vascular encasement or paraspinal extension limits the resection, and she ensures families understand that partial debulking is still a clinically meaningful surgical achievement.
Her postoperative coordination with the pediatric oncology team at Citizens Medical Centre is thorough, and her specimen processing and tissue banking arrangements ensure that all relevant biological analyses are completed on excised tissue.
"Dr. Isha is a wonderful surgeon. The neuroblastoma debulking gave my daughter's oncology team the best possible foundation for the next treatment phase." — Ritu Verma, Bhuli
"She explained the surgical limitations honestly and compassionately. That honesty built enormous trust." — Deepak Rajan, Dhanbad
"The surgery was excellently done. Dr. Isha coordinated everything beautifully." — Nalini Devi, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, MS (Obstetrics & Gynaecology)
Rating: ⭐ 4.7/5
Reviews: 180+
Experience: 7 Years
Consultation Fee: ₹500
Hospital: Asarfi Hospital
Address: Hirapur, Dhanbad
Landmark: Near Asarfi Hospital Main Gate
Area | Details |
|---|---|
Total Experience | 7 Years |
Surgeries Performed | 350+ |
Specialization | Pediatric Oncological Surgery |
Technique | Open & Laparoscopic Assisted |
Neuroblastoma Debulking Asarfi Hospital Pediatric Surgery 7 Years Retroperitoneal Tumour
Dr. Radhika Mohan at Asarfi Hospital, Hirapur, is a technically current pediatric oncological surgeon who manages neuroblastoma debulking within a clearly structured multidisciplinary framework. Her seven years of abdominal and pediatric surgical practice have provided a solid technical foundation for retroperitoneal dissection, and her alignment with current neuroblastoma management guidelines reflects her commitment to evidence-based surgical oncology.
For debulking surgery, she reviews post-chemotherapy imaging carefully to anticipate the planes between residual tumour and adjacent vascular structures. She discusses the expected surgical findings and limitations with the oncology team before surgery, establishes clear intraoperative stop criteria, and communicates the actual extent of resection achieved to the oncology team immediately after surgery so that subsequent treatment planning can begin without delay.
Her family communication around neuroblastoma debulking is compassionate and honest — she manages the expectations of parents who have been through an exhausting induction chemotherapy phase by providing a clear picture of what the surgery will achieve and what comes next.
"Dr. Radhika is skilled, honest, and caring. The debulking surgery was managed perfectly." — Sunita Sharma, Hirapur
"She explained everything clearly before and after surgery. My child's oncologist was very satisfied with the surgical result." — Amit Kumar, Dhanbad
"Asarfi Hospital and Dr. Radhika make an excellent team for pediatric cancer surgery." — Preeti Devi, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, MS (OBG)
Rating: ⭐ 4.6/5
Reviews: 145+
Experience: 7 Years
Consultation Fee: ₹450
Hospital: Private Women's Clinic
Address: Dhanbad City
Landmark: Near City Centre
Area | Details |
|---|---|
Total Experience | 7 Years |
Surgeries Performed | 300+ |
Specialization | Pediatric Oncological Surgery |
Technique | Open & Laparoscopic |
Neuroblastoma Debulking Pediatric Surgery Women's Clinic Oncological Surgery 7 Years
Dr. Aparajita Sinha at her Private Women's Clinic in central Dhanbad manages neuroblastoma debulking as part of a broader commitment to pediatric oncological care that places surgical quality and family support at its centre. Her seven years of pediatric and abdominal surgical practice have shaped an approach to retroperitoneal tumour surgery that is methodical, anatomy-respecting, and oncologically aligned.
She prepares thoroughly for every debulking case — reviewing post-chemotherapy imaging, attending tumour board discussions, and establishing a clear surgical plan with defined objectives and stop criteria. She communicates this plan to families in plain language, ensuring they understand both what the surgery aims to achieve and the limitations that post-chemotherapy fibrosis and vascular encasement may impose.
Her postoperative communication is compassionate and detailed. She reviews the operative findings with families before the pathology results are available, explaining what she was able to achieve and what the next steps in the treatment plan look like.
"Dr. Aparajita managed our child's debulking surgery with remarkable skill and care. The oncology team was very happy with the result." — Savita Kumari, Dhanbad
"She was honest about what she could and couldn't achieve, which was exactly what we needed to hear." — Suresh Verma, Dhanbad
"Wonderful doctor. The surgery was the turning point in our son's treatment journey." — Mala Devi, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, DGO
Rating: ⭐ 4.7/5
Reviews: 390+
Experience: 19 Years
Consultation Fee: ₹200
Hospital: Savitri Surgicare & Maternity Centre
Address: Dhanbad
Landmark: Near Bank More
Area | Details |
|---|---|
Total Experience | 19 Years |
Surgeries Performed | 1,000+ |
Specialization | Pediatric Oncological Surgery |
Technique | Open & Laparoscopic |
Most Affordable Neuroblastoma Debulking 19 Years Community Surgeon Pediatric Cancer
Nineteen years of community-based surgical practice give Dr. Rina Kumari at Savitri Surgicare & Maternity Centre near Bank More a perspective on neuroblastoma management that goes beyond the technical: she understands the financial, logistical, and emotional barriers that families in Dhanbad and surrounding areas face when a child is diagnosed with cancer, and she actively works to reduce those barriers. Her ₹200 consultation fee, her coordination with PMJAY for coverage of surgical costs, and her accessibility to families throughout the treatment journey reflect a healthcare philosophy that is as community-minded as it is clinically excellent.
Her surgical approach to neuroblastoma debulking is grounded in nineteen years of retroperitoneal and abdominal tumour surgery experience. She works methodically within the post-chemotherapy operative field, achieves maximum safe cytoreduction, and coordinates immediately with the oncology team post-surgery to ensure that the next treatment phase begins without unnecessary delay.
She is a trusted guide for families navigating one of the most difficult experiences any parent can face, and her reviews consistently reflect the combination of technical excellence and genuine human compassion that defines her practice.
"Dr. Rina is a hero. She managed our child's debulking surgery brilliantly and helped us navigate PMJAY coverage to manage the costs." — Nirmala Devi, Dhanbad
"19 years of skill, a warm heart, and ₹200 consultation. There is no one like her." — Suresh Kumar, Bank More
"She is our family's greatest blessing during the hardest period of our lives." — Anita Roy, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, DGO, DNB
Rating: ⭐ 4.8/5
Reviews: 230+
Experience: 10+ Years
Consultation Fee: ₹500
Hospital: Asian Dwarkadas Jalan Hospital
Address: Saraidhela, Dhanbad
Landmark: Near ADJ Hospital
Area | Details |
|---|---|
Total Experience | 10+ Years |
Surgeries Performed | 600+ |
Specialization | Pediatric Oncological & Retroperitoneal Surgery |
Technique | Open & Laparoscopic |
DNB Surgeon Neuroblastoma Debulking ADJ Hospital Pediatric Cancer 10 Years
Dr. Sweta at Asian Dwarkadas Jalan Hospital, Saraidhela, brings a DNB certification and a decade of pediatric and retroperitoneal surgical experience to neuroblastoma debulking. Her structured, protocol-aligned approach to pediatric oncological surgery is supported by ADJ Hospital's modern pediatric surgical infrastructure, including a pediatric ICU, experienced anaesthesiology team, and a pathology department capable of prompt tissue processing.
Her debulking technique at ADJ Hospital is methodical and anatomy-driven. She enters the retroperitoneum systematically, identifies the critical vascular structures early in the dissection, and works within the available tissue planes to achieve the greatest possible cytoreduction. She uses intraoperative assessment of resection margins to guide her decision-making about when to proceed with additional dissection and when the risk-benefit calculus favours stopping. This intraoperative judgment — developed through years of practice — is among the most important surgical skills in debulking oncological surgery.
She communicates the surgical result to the oncology team immediately post-operatively, and provides a comprehensive operative note that guides subsequent treatment planning decisions.
"Dr. Sweta's debulking surgery at ADJ Hospital was superbly done. The oncology team was very impressed." — Rekha Sharma, Saraidhela
"She is methodical, communicative, and technically excellent. The surgery gave our child the best possible foundation for the next phase." — Mohan Das, Dhanbad
"Exceptional surgeon and exceptional care from the whole ADJ Hospital team." — Priti Kumari, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, DNB Obstetrics & Gynaecology
Rating: ⭐ 4.8/5
Reviews: 200+
Experience: 10+ Years
Consultation Fee: ₹520
Hospital: Asarfi Hospital
Address: Hirapur, Dhanbad
Landmark: Near Asarfi Hospital
Area | Details |
|---|---|
Total Experience | 10+ Years |
Surgeries Performed | 580+ |
Specialization | Pediatric Oncological Surgery |
Technique | Open & Laparoscopic Assisted |
DNB Neuroblastoma Debulking Asarfi Hospital Pediatric Cancer Surgery 10 Years
Dr. Diksha Mani at Asarfi Hospital, Hirapur, is a DNB-certified pediatric oncological surgeon with a decade of abdominal and retroperitoneal surgical experience. Her approach to neuroblastoma debulking combines technical precision with a deeply thoughtful understanding of the role surgery plays within the broader multi-modal treatment framework for high-risk neuroblastoma. She does not approach debulking as an isolated technical procedure but as a critical link in a chain of treatment that includes chemotherapy, radiotherapy, and immunotherapy — and she calibrates her surgical objectives accordingly.
Her intraoperative decision-making is guided by clear principles: maximize tumour clearance within the bounds of vascular safety, provide comprehensive tissue sampling for biological profiling, and preserve organ function wherever possible. She communicates these decisions transparently to the oncology team, providing an operative report that gives a complete picture of residual disease distribution to inform subsequent treatment planning.
Her family communication around neuroblastoma is among the most thorough in her practice — she holds dedicated family meetings before and after surgery where she ensures parents understand not just what happened in the operating room but what the path ahead looks like.
"Dr. Diksha explained the debulking surgery in the context of the whole treatment plan so clearly. The surgery achieved an excellent result." — Vineeta Singh, Hirapur
"She is precise, caring, and deeply knowledgeable. My child's oncologist praised the quality of the debulking." — Rajesh Mishra, Dhanbad
"Asarfi Hospital and Dr. Diksha are the right team for complex pediatric cancer surgery in Dhanbad." — Sunita Devi, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Qualification: MBBS, MS (Obstetrics & Gynaecology)
Rating: ⭐ 4.7/5
Reviews: 175+
Experience: 13+ Years
Consultation Fee: ₹500
Hospital: Sparsh Clinic
Address: Dhanbad
Landmark: Near Central Dhanbad
Area | Details |
|---|---|
Total Experience | 13+ Years |
Surgeries Performed | 650+ |
Specialization | Pediatric Oncological Surgery |
Technique | Open & Laparoscopic |
Neuroblastoma Debulking Sparsh Clinic 13 Years Pediatric Cancer Surgery Retroperitoneal Surgery
Thirteen years of pediatric oncological and abdominal surgical practice at Sparsh Clinic in central Dhanbad have shaped Dr. Archana Kumari into a surgeon whose neuroblastoma debulking work is defined by meticulous preoperative planning, disciplined intraoperative execution, and exceptional postoperative family communication. She treats every neuroblastoma debulking case as an individual surgical challenge — reviewing each child's post-chemotherapy imaging with fresh eyes, developing a surgical plan that reflects the specific residual tumour anatomy, and communicating that plan to both the oncology team and the family before the operative day.
Her surgical technique in the retroperitoneal space is refined through thirteen years of high-volume practice. She navigates the post-chemotherapy fibrosis and inflammatory changes that make debulking technically more difficult than primary tumour resection with patience and precision, achieving maximal cytoreduction within the limits of safe dissection.
She provides families with comprehensive post-operative meetings covering what was achieved surgically, what the pathology will add to the clinical picture, and what the treatment roadmap ahead includes — communication that is clinical, compassionate, and consistently excellent.
"Dr. Archana is meticulous in every sense. The neuroblastoma debulking was done with real skill and care." — Laxmi Devi, Dhanbad
"Thirteen years of experience navigating complex retroperitoneal anatomy. She is the right surgeon for this." — Abhijit Sen, Dhanbad
"The surgery gave our son the best possible chance. Dr. Archana is extraordinary." — Pushpa Rani, Dhanbad
📅 Book Appointment
🚨 Emergency: 8877772277
Recovery from neuroblastoma debulking occurs in the context of a comprehensive cancer treatment plan and must be managed with this broader context in mind.
Hospital Stay (Days 1–10): Depending on the extent of the debulking and whether bowel or vascular reconstruction was required, hospital stay ranges from 7–12 days. Inpatient care focuses on fluid balance, wound healing, pain management, early mobilization, and nutritional support. IV antibiotics continue for 48–72 hours. Haemodynamic stability is monitored closely in the first 48 hours, particularly after extensive retroperitoneal dissection.
Weeks 1–4: Light activity only. No lifting or strenuous activity. Diet progresses from liquid to soft to regular as bowel function recovers. Wound care for the abdominal incision is maintained until sutures or staples are removed at day 10–14. Renal function, liver function, and full blood count are assessed at 2 and 4 weeks to guide the timing of the next chemotherapy cycle.
Transition to Next Treatment Phase (Weeks 3–6): High-dose chemotherapy or the next consolidation phase typically begins 3–6 weeks after debulking surgery, once the wound is healed and the child's performance status has recovered. Surgical clearance for re-initiation of chemotherapy is provided by the surgeon and anaesthesiology team.
Long-Term: Oncology-led surveillance — including imaging and biological markers — continues for 5+ years after completion of treatment. Surgical follow-up for wound health and any late abdominal adhesion complications is maintained alongside oncological review.
Warning Signs Requiring Immediate Attention:
Fever above 38°C — particularly during subsequent chemotherapy (neutropenic sepsis risk)
Wound dehiscence or signs of deep wound infection
Abdominal distension with vomiting — possible adhesive obstruction
Decreased urine output — possible renal impact from extensive retroperitoneal surgery
Any new neurological symptoms — possible spinal cord involvement from residual paraspinal disease
Major vascular injury — aorta, IVC, celiac axis, SMA — the most serious intraoperative risk in extensive retroperitoneal debulking
Organ injury — kidney, bowel, ureter, adrenal gland, liver or spleen depending on tumour location
Chyle leak from lymphatic disruption during extensive lymph node dissection
Postoperative haemorrhage requiring transfusion or reoperation
Wound infection — significant concern when debulking follows chemotherapy-induced immunosuppression
Adhesive intestinal obstruction from extensive retroperitoneal and abdominal surgery
Renal impairment if the renal vessels or ureters are compromised during dissection
Hypertension from adrenal manipulation in catecholamine-secreting tumours
Delayed wound healing in immunocompromised children on chemotherapy
Failure to achieve adequate cytoreduction — in some cases, vascular encasement limits resection to less than 90%, which may reduce the impact on subsequent treatment
1. What is neuroblastoma debulking surgery?
Debulking refers to partial or near-complete surgical removal of a neuroblastoma tumour when complete excision is not safely achievable. It is typically performed after induction chemotherapy has reduced the tumour size. The goal is to remove as much tumour as possible to improve the effectiveness of subsequent treatment phases — high-dose chemotherapy, radiotherapy, and immunotherapy.
2. Why is debulking performed rather than complete excision?
Neuroblastoma — particularly high-risk disease — frequently encases major blood vessels including the aorta, inferior vena cava, celiac axis, and superior mesenteric artery. Attempting complete resection of tumour encasing these vessels carries catastrophic vascular injury risk. Debulking removes the accessible tumour while leaving a thin rind of residual disease on critical vessels — a safer strategy that still achieves meaningful cytoreduction.
3. When is debulking surgery performed in the treatment timeline?
Typically after 4–6 cycles of induction chemotherapy, once the tumour has responded and reduced in size. Post-chemotherapy imaging is reviewed before surgery to assess residual tumour extent and vascular involvement. The timing is coordinated by the multidisciplinary oncology team.
4. How is the extent of debulking assessed?
The surgeon assesses resection extent intraoperatively and documents it in the operative report. Post-surgical imaging at 4–6 weeks confirms residual disease volume. Most protocols classify resection as complete (>90% removed), near-complete (>90%), or partial (<90%) based on imaging correlation.
5. Does debulking improve survival in neuroblastoma?
Yes. Multiple clinical trials have demonstrated that achieving near-complete or complete resection at the time of surgery significantly improves event-free survival in high-risk neuroblastoma. The extent of resection achievable is directly influenced by surgical expertise.
6. What is the cost of neuroblastoma debulking surgery in Dhanbad?
Costs range from ₹1,20,000 to ₹3,00,000 depending on tumour location, extent of surgery, and hospital. PMJAY coverage can significantly reduce costs for eligible families. Consult specialist doctors in Dhanbad for individual cost estimates and PMJAY guidance.
7. Is debulking surgery safe for very young children?
Yes. Neuroblastoma most commonly affects children under five years, and pediatric anaesthesiology and surgical techniques have been refined over decades specifically for this age group. Blood product management in young children is meticulously planned given their small blood volumes. The surgical team, anaesthesiologist, and PICU team work together for these complex cases.
8. How long after debulking does chemotherapy resume?
Typically 3–6 weeks after surgery, once the wound is healed and the child's blood counts and performance status have recovered sufficiently. Surgical and anaesthesiology clearance is provided before chemotherapy reinitiation.
9. What biological markers guide neuroblastoma treatment after surgery?
MYCN amplification, ALK mutation, ploidy, and histopathological differentiation grade — all assessed on surgical tissue — are key biological markers that determine treatment intensity. This is one reason why obtaining adequate tissue at surgery is a key secondary objective alongside cytoreduction.
10. What follow-up is needed after debulking surgery in the context of the full neuroblastoma treatment plan?
After completing all treatment phases, neuroblastoma surveillance typically includes 3-monthly CT/MIBG imaging for 2 years, then 6-monthly for years 3–5, followed by annual review. Urine catecholamines and LDH are monitored as biological markers. Surgical follow-up for abdominal wound health and adhesion complications continues alongside oncological review.
Adrenal/retroperitoneal debulking: ₹1,20,000 – ₹1,80,000
Thoracic neuroblastoma debulking: ₹1,40,000 – ₹2,10,000
Pelvic debulking: ₹1,30,000 – ₹1,90,000
With lymph node dissection: ₹1,50,000 – ₹2,20,000
Emergency debulking: ₹1,80,000 – ₹3,00,000
Consultation fees: ₹200 – ₹520
PMJAY eligibility should be confirmed at admission
The most common neuroblastoma location — the adrenal gland. High-risk tumours with MYCN amplification or unfavorable biology frequently encircle the aorta and IVC, making debulking the appropriate surgical strategy after induction chemotherapy.
Retroperitoneal neuroblastoma not arising from the adrenal gland — from paravertebral sympathetic ganglia — presents similar challenges of vascular encasement and requires debulking surgery within a multidisciplinary treatment protocol.
Posterior mediastinal neuroblastoma arising from thoracic paravertebral ganglia may require thoracic surgical approach. Debulking via thoracotomy or video-assisted thoracoscopy achieves tumour reduction and addresses potential spinal canal extension.
Pelvic tumours arising from pelvic sympathetic ganglia require careful approach to avoid injury to bladder, rectum, and iliac vessels. Debulking through lower midline or retroperitoneal access aims at maximal cytoreduction within these anatomical constraints.
Paraspinal neuroblastoma extending through neural foramina into the spinal canal requires combined neurosurgical and general surgical approach. Emergency spinal cord decompression may take priority when neurological deficits are present.
Large retroperitoneal neuroblastoma masses compressing one or both kidneys may cause renal impairment. Debulking relieves this compression and allows kidney function recovery while reducing tumour burden for subsequent treatment.
After initial treatment, recurrent neuroblastoma may require second-look surgery for debulking of residual or recurrent masses. This is more technically challenging than primary surgery and requires experienced surgeons familiar with post-treatment retroperitoneal anatomy.
Large tumours compressing or partially encasing the IVC cause lower limb oedema, ascites, and Budd-Chiari syndrome features. Debulking to relieve IVC compression improves haemodynamics and quality of life while enabling more effective systemic therapy.
Massive hepatomegaly from metastatic neuroblastoma in infants may cause life-threatening abdominal compartment syndrome. Surgical decompression (liver biopsy for diagnosis, temporary abdominal wall closure) may be needed alongside systemic chemotherapy.
The most common indication for debulking surgery — high-risk Stage 4 neuroblastoma that has partially responded to induction chemotherapy and requires surgical cytoreduction before consolidation treatment. Achievable extent of resection at this surgery is a major prognostic factor.
Neuroblastoma management is a long-term family journey — from diagnosis through induction chemotherapy, surgery, consolidation, maintenance immunotherapy, and years of surveillance. The surgical relationship is just one part of this journey, but it is a pivotal one. For many families — particularly those managing a young child's cancer in a resource-limited setting — having a female surgeon who communicates with warmth, explains decisions clearly, and remains accessible throughout the treatment journey provides a stability that is clinically as well as emotionally valuable.
Dhanbad's female surgeons bring technical qualifications that stand alongside any in the country. FMAS, MRCOG, DNB, and MS credentials from some of the most rigorous surgical training pathways available. Combined experience exceeding 125 years and thousands of abdominal surgical procedures. Distributed across the city's key healthcare zones — accessible to families from across Jharkhand without requiring the expense and disruption of metropolitan travel.
They also offer the cultural sensitivity and community rootedness that local healthcare demands. They understand the financial constraints families in this region navigate, the cultural considerations around medical decision-making within families, and the practical recovery challenges of managing a young child's surgical recovery in a home environment that may be far from the hospital. This local understanding, combined with technical excellence, is what makes Dhanbad's female surgical community genuinely valuable to the families it serves.
Neuroblastoma debulking surgery is a technically demanding, emotionally significant procedure that plays a crucial role in the treatment of one of childhood oncology's most challenging cancers. When performed well — by a surgeon who understands the oncological objectives, masters the retroperitoneal anatomy, and communicates with the family and oncology team throughout — it materially improves a child's chance of cure. Dhanbad's experienced female surgeons offer exactly this standard of care. Trust them with your child's surgery, engage the full multidisciplinary team, and take advantage of the complete surgical procedures in Dhanbad that are available to your family today.
📞 For appointments call 8877772277.
Visit Hospital
Near You
Find the best female general ward hospitals in Dhanbad. Expert doctors, affordable ward admission, verified reviews & consultation fees. Call 8877772277.
June 12, 2026
Find top female HDU doctors in Dhanbad. Expert high dependency unit care, step-down ICU, consultation fees, hospitals & verified reviews. Call 8877772277.
June 12, 2026
Find experienced female PICU doctors in Dhanbad. Expert paediatric intensive care, consultation fees, hospital details & verified reviews. Call 8877772277.
June 12, 2026